CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...
Please provide your email address to receive an email when new articles are posted on . An AI model showed tumor size to be an independent risk factor for prostate cancer metastasis and recurrence. AI ...
MRI reports and biopsy pathology reports were extracted from a cohort of 1,360,866 patients with PCa in the VA Cancer Registry System or the VA Corporate Data Warehouse, with 155,570 patients having ...
Evaluating the rates of surgical overtreatment of prostate cancer. Result of ROC curve analysis and decision curve analysis about S2,3PSA% for reclassification at 1st repeat biopsy. ROC curves about ...
Among US men with grade group 1 (GG1) prostate cancer, about 1 in 6 had intermediate- or high-risk disease, along with increased rates of adverse pathology and cancer-specific mortality. This finding ...
A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable improvement in urinary symptoms and flow rate, according to data from three ...
Lee et al, 1 comprising authors from a number of institutions, published a retrospective observational study conducted on 147 consecutive patients who underwent endoscopic enucleation of the prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results